FC
AVNS

FORA Capital’s Avanos Medical AVNS Stock Holding History

FORA Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-665
Closed -$20K – 659
2020
Q2 		$20K Buy
+665
New +$19.3K 0.01% 801
2020
Q1 		– Sell
-3,721
Closed -$125K – 1030
2019
Q4 		$125K Buy
+3,721
New +$135K 0.01% 720

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FORA Capital's AVNS Position: Q3 2020 in Review

FORA Capital sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 665 shares — an estimated $20K sold.

FORA Capital first reported a position in AVNS in Q4 2019 and held it in 2 quarters. The position peaked at $125K in Q4 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • FORA Capital reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • FORA Capital sold 665 Avanos Medical shares in Q3 2020, an estimated $20K.
  • FORA Capital first reported a position in Avanos Medical in Q4 2019 and held it in 2 quarters.
  • FORA Capital's Avanos Medical position peaked at $125K in Q4 2019.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on FORA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.